ADVFN US – Market Content Editor

  • U.S. stocks set for cautious start ahead of key inflation data: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. stocks set for cautious start ahead of key inflation data: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. stock futures pointed to a broadly flat opening on Monday, with investors showing little appetite for major positions following last week’s strong rally and ahead of closely watched inflation figures due in the coming days. With little scheduled on the domestic economic calendar on Monday, traders are likely to assess the recent advance on…

  • AirSculpt Technologies shares plunge 13% after revenue miss and weaker EBITDA outlook

    AirSculpt Technologies shares plunge 13% after revenue miss and weaker EBITDA outlook

    AirSculpt Technologies, Inc. (NASDAQ:AIRS) shares tumbled 13.17% in pre-market trading on Monday after the body contouring specialist reported second-quarter fiscal 2026 revenue below Wall Street expectations and lowered its full-year adjusted EBITDA forecast. The company delivered adjusted earnings of $0.01 per share, matching analyst expectations. However, quarterly revenue of $42.9 million fell short of the…

  • HPE shares jump 5% as Morgan Stanley upgrade points to nearly 30% upside

    HPE shares jump 5% as Morgan Stanley upgrade points to nearly 30% upside

    HP Enterprise (NYSE:HPE) shares climbed 5% in Monday’s pre-market trading after Morgan Stanley upgraded the enterprise technology company from “Equalweight” to “Overweight,” citing an increasingly attractive outlook for earnings, cash generation and valuation. The investment bank set a $69 price target on HPE. Compared with Friday’s closing price of $53.22, that implies potential upside of…

  • Ceva shares slip despite Q2 earnings beat and stronger licensing revenue

    Ceva shares slip despite Q2 earnings beat and stronger licensing revenue

    Ceva, Inc. (NASDAQ:CEVA) shares fell 3.32% in pre-market trading on Monday despite the semiconductor intellectual property company reporting second-quarter earnings and revenue above Wall Street expectations. Adjusted earnings reached $0.08 per share, slightly ahead of the analyst consensus estimate of $0.07. Revenue came in at $29.0 million, exceeding expectations of $28.14 million and increasing 13%…

  • MarineMax shares surge on report of $1.5 billion Safe Harbor takeover

    MarineMax shares surge on report of $1.5 billion Safe Harbor takeover

    MarineMax Inc. (NYSE:HZO) shares soared more than 34% to around $47.80 in pre-market trading on Monday following a report that Safe Harbor Marinas, owned by Blackstone Infrastructure, is nearing an agreement to acquire the recreational boating company. According to Reuters, citing people familiar with the discussions, the proposed transaction would value MarineMax at approximately $1.5…

  • Monday.com shares fall as cautious Q3 guidance overshadows earnings beat

    Monday.com shares fall as cautious Q3 guidance overshadows earnings beat

    Monday.com (NASDAQ:MNDY) shares dropped 5.5% in pre-market trading after the work management software company reported better-than-expected second-quarter results but issued third-quarter revenue guidance below Wall Street forecasts. Adjusted earnings came in at $1.48 per share, significantly ahead of the analyst consensus estimate of $1.11. Revenue increased 22% year-on-year to $364.6 million, beating expectations of $355.53…

  • International Seaways shares gain as record Q2 profit beats expectations

    International Seaways shares gain as record Q2 profit beats expectations

    International Seaways, Inc. (NYSE:INSW) shares rose 2.26% on Monday after the tanker operator delivered second-quarter results comfortably ahead of Wall Street forecasts, supported by substantially stronger shipping rates and record profitability. Adjusted earnings reached $5.91 per share, exceeding the analyst consensus estimate of $5.52 by $0.39. Quarterly revenue surged to $467.29 million, well above the…

  • Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint

    Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint

    Sionna Therapeutics (NASDAQ:SION) shares plunged 92% on Monday after the biotechnology company reported disappointing results from its Phase 2a proof-of-concept study of SION-719 in cystic fibrosis. The PreciSION CF trial failed to achieve its key activity endpoint, which measured the reduction in sweat chloride when SION-719 was administered alongside the standard-of-care treatment Trikafta. The study…

  • Camtek stock advances as record Q2 revenue and upbeat guidance impress investors

    Camtek stock advances as record Q2 revenue and upbeat guidance impress investors

    Camtek Ltd. (NASDAQ:CAMT) shares climbed 3.64% in pre-market trading on Monday after the semiconductor equipment specialist reported better-than-expected second-quarter results and outlined expectations for a significant acceleration in growth during the remainder of 2026. The company generated adjusted earnings of $0.78 per share, coming in $0.03 above the Wall Street consensus forecast of $0.75. Revenue…

  • AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

    AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

    AbCellera (NASDAQ:ABCL) shares jumped 22% on Monday after the biotechnology company announced positive topline results from a Phase 2 clinical trial evaluating ABCL635 as a potential treatment for moderate-to-severe vasomotor symptoms associated with menopause. The study achieved its primary efficacy endpoints, demonstrating statistically significant reductions in both the frequency and severity of moderate-to-severe vasomotor symptoms…